Rehabilitation of Stroke Patients for Maximal Neurological Restoration
PROTEQT
Training the Surviving Neural Network to Create New Synaptic Connections That Can Maximize Restoration of Motor Functions After Stroke
1 other identifier
observational
200
1 country
3
Brief Summary
Multimodal imaging of stroke patients. Patients included in the study will be investigated with multiparametric imaging tools including MRI and EEG imaging. Improvements in motor skills will be monitored clinically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2021
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2021
CompletedFirst Posted
Study publicly available on registry
October 20, 2021
CompletedStudy Start
First participant enrolled
November 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedNovember 30, 2023
November 1, 2023
2.2 years
May 25, 2021
November 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Changes in brain volume
Stroke induced brain volume changes (mm3) will be measured using magnetic resonance imaging (MRI) at 1 day and 6 months post-stroke.
6 months
Stroke induced changes in brain activity.
Document longitudinal changes in brain activity using EEG. Changes will be measured in cycles/second (Hertz, Hz).
6 months
Changes in inflammatory activity in brain
Markers of post-stroke inflammation will be measured in pg/ml and ng/ml.
6 months
muscle function
Longitudinal kinematic profiling. Electromyography measurements of muscle function post-stroke will be measured in cycles/second (Hz) and amplitude (mm). Extension and flexion of arm will be measured in cm. Joint angles will be measured in degrees. Speed of flexion and extension will be measured in cm/second
6 months
Study Arms (2)
Stroke patients
Stroke patients admitted to the stroke unit, St Olav´s hospital, Trondheim, Norway, without previous stroke, neurological disease or central nervous system (CNS) trauma, will be eligible for inclusion into the study. The planned cohort size is 135 patients.
healthy volunteers
Age and gender matched controls without previous CNS disease or trauma are eligible for inclusion into the study. Estimated cohort size is 45 individuals. Volunteers will be recruited through announcement in local newspaper.
Interventions
moving arm/leg while registration with electromyography, electroencephalogram, accelerometers, functional near infrared spectroscopy and 3 dimensional video registration of hand, arm, foot and leg movements.
Eligibility Criteria
Patients 18-years or older of both sexes with subcortical strokes resulting in arm motor deficit, admitted to the stroke unit, St Olav´s Hospital during 2020-2023. All patients admitted to the stroke unit will be scored according to National Institute of Health Score Scale (NIHSS) and the modified Rankin score (mRS) to establish the baseline clinical assessment of neurological dysfunction prior to inclusion
You may qualify if:
- subcortical strokes resulting in arm motor deficits.
- admitted to the stroke unit, St Olav´s Hospital during 2021-2023
You may not qualify if:
- Previous stroke
- neurodegenerative disease
- brain tumors
- previous neurotrauma or brain operation
- aphasia
- cognitive dysfunction and claustrophobia preventing MRI examinations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
- OsloMetcollaborator
Study Sites (3)
OsloMet
Oslo, Norway
NextMove, NTNU
Trondheim, Norway
St Olavs Hospital Stroke Unit
Trondheim, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Axel Sandvig, PhD prof
Norwegian University of Science and Technology
- STUDY DIRECTOR
Jorunn Helbostad, PhD prof
Norwegian University of Science and Technology
- STUDY DIRECTOR
Bent Indredavik, PhD prof
St. Olavs Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2021
First Posted
October 20, 2021
Study Start
November 11, 2021
Primary Completion
February 1, 2024
Study Completion
February 1, 2024
Last Updated
November 30, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share